Your browser doesn't support javascript.
loading
Divalent nanobodies to platelet CLEC-2 can serve as agonists or antagonists.
Clark, Joanne C; Martin, Eleyna M; Morán, Luis A; Di, Ying; Wang, Xueqing; Zuidscherwoude, Malou; Brown, Helena C; Kavanagh, Deirdre M; Hummert, Johan; Eble, Johannes A; Nieswandt, Bernhard; Stegner, David; Pollitt, Alice Y; Herten, Dirk-Peter; Tomlinson, Michael G; García, Angel; Watson, Steve P.
Afiliación
  • Clark JC; Institute of Cardiovascular Sciences, Level 1 IBR, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK. j.clark.5@bham.ac.uk.
  • Martin EM; Centre of Membrane Proteins and Receptors (COMPARE), The Universities of Birmingham and Nottingham, The Midlands, UK. j.clark.5@bham.ac.uk.
  • Morán LA; Institute of Cardiovascular Sciences, Level 1 IBR, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
  • Di Y; Institute of Cardiovascular Sciences, Level 1 IBR, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
  • Wang X; Centre for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela, and Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain.
  • Zuidscherwoude M; Institute of Cardiovascular Sciences, Level 1 IBR, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
  • Brown HC; Institute of Cardiovascular Sciences, Level 1 IBR, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
  • Kavanagh DM; Centre for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela, and Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain.
  • Hummert J; School of Biosciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
  • Eble JA; Institute of Cardiovascular Sciences, Level 1 IBR, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
  • Nieswandt B; Centre of Membrane Proteins and Receptors (COMPARE), The Universities of Birmingham and Nottingham, The Midlands, UK.
  • Stegner D; Institute of Cardiovascular Sciences, Level 1 IBR, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
  • Pollitt AY; Institute of Experimental Biomedicine I, University Hospital and Rudolf Virchow Center for Integrative and Translational Bioimaging, University of Würzburg, Würzburg, Germany.
  • Herten DP; Department of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 QU3, UK.
  • Tomlinson MG; Institute of Cardiovascular Sciences, Level 1 IBR, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
  • García A; Centre of Membrane Proteins and Receptors (COMPARE), The Universities of Birmingham and Nottingham, The Midlands, UK.
  • Watson SP; Institute for Physiological Chemistry & Pathobiochemistry, University of Münster, Waldeyerstraße 15, 48149, Münster, Germany.
Commun Biol ; 6(1): 376, 2023 04 07.
Article en En | MEDLINE | ID: mdl-37029319
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Lectinas Tipo C / Anticuerpos de Dominio Único Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Commun Biol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Lectinas Tipo C / Anticuerpos de Dominio Único Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Commun Biol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido